LGND Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ligand Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 304.775 USD 3.31% Market Closed

Market Cap: $6.1B

	Ligand Pharmaceuticals Inc NASDAQ:LGND	US
	Real Consulting SA F:K2Q	GR
	Oji Holdings Corp OTC:OJIPY	JP
	Cortina Holdings Ltd SGX:C41	SG

Profitability Summary

Ligand Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

93%

Gross Margin is Increasing

77% > 95%

Exceptional Operating Margin

32%

Low 3Y Average Operating Margin

Operating Margin is Increasing

19% > 32%

Exceptional Net Margin

68%

Sustainable 3Y Average Net Margin

24%

Net Margin is Increasing

13% > 68%

Exceptional Free Cash Flow Margin

46%

Strong 3Y Average Free Cash Flow Margin

19%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.